PsyBio Therapeutics Corp. (OTCPK: PSYB.F)
Health Care · Biotechnology · US
$—
— today · — 1Y
PsyBio Therapeutics Corp. (OTCPK: PSYB.F) operates in the Biotechnology industry within the Health Care sector. The company is valued at $133.00 and employs 4 people.
trading between 0.00 and 0.00.
Tweenvest scores PsyBio Therapeutics Corp. across four factors: quality 14/100, value 19/100. Its strongest factor is value.
PSYB.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $133.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -860.05
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 132.61M
- Employees
- 4
- Next earnings
- —
About PsyBio Therapeutics Corp.
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
- ISIN
- CA6936971044
- Founded
- 2009
- Listed since
- Feb 25, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Regenicin, Inc.OTCPK: RGIN | $153.00 | $— | — |
| Immage Biotherapeutics Corp.OTCPK: IMMG | $152.00 | $— | — |
| Poniard Pharmaceuticals, Inc.OTCPK: PARD | $150.00 | $0.00 | — |
| NexImmune, Inc.OTCPK: NEXI | $139.00 | $— | — |
| Marizyme, Inc.OTCPK: MRZM | $132.00 | $— | — |
| Lattice Biologics Ltd.OTCPK: LBLT.F | $128.00 | $— | — |
| Navidea Biopharmaceuticals, Inc.OTCPK: NAVB.Q | $100.00 | $0.00 | -99.00% |
| Infinity Pharmaceuticals, Inc.OTCPK: INFI.Q | $91.00 | $0.00 | -99.00% |
Figures last refreshed Oct 18, 2026.